420 with CNW — The Unique Benefits of Marijuana
Post# of 527
(Total Views: 175)
Posted On: 12/12/2022 5:29:15 PM
420 with CNW — The Unique Benefits of Marijuana to the Bipolar Community
Cannabis has proved to have an effect in improving cognitive functions all the while helping to reduce risky decision-making, new research has found. Currently, more than 40 million people suffer from bipolar disorders globally. Bipolar disorder, or manic depression, has catastrophic effects on one’s daily endeavors including relationships and work processes. In this data, a good number of people suffer mild or extreme aspects of bipolar disorder but are unaware of the diagnosis.
Bipolar disorder is categorized in two main sets: bipolar I, where one exhibits manic episodes lasting a week or so, such an individual may need hospitalization; and bipolar II, where a patient presents with manic depressive episodes and elevated mood swings that could agitate the patient. Those agitating episodes could lead to high energy in the patients. The patient could also exhibit a cyclothymic disorder where they present with cyclical rapid high-low emotions or mood swings. These mood swings alternate from high-energy excitedness to a depressive dip in a small span of time.
Conventional medicine has been of help in alleviating the symptoms. However, many patients under conventional psychotic drugs do not seem to find much relief because, for one, the drugs take a long time before the effects kick in, and these drugs come with a myriad of side effects. Cannabis has come in handy as a natural and safe alternative for bipolar patients.
In a new study, researchers presented some findings in the Neuroscience 2022 conference seeking to understand how cannabis affects the cognitive and goal-directed behaviors among people with bipolar disorder. This study revealed that marijuana may have uniquely beneficial effects for those consuming it chronically. Researchers said that marijuana was effective specifically in improving cognitive function while also reducing risky decision-making. The researchers also deduced that cannabis reduces the dopaminergic activity in the brain to suppress bipolar symptoms.
There have been other older studies that produced similar findings. In a 2018 clinical trial, researchers discovered that consumption of cannabis improved the clinical symptoms of bipolar disorder. This was the first-ever clinical trial to be conducted with the aim of understanding how marijuana affects neuropsychological performance.
Researchers from Harvard Medical School, in conjunction with other scientists, studied the impact of cannabis on cognitive function and mood among bipolar patients. They found that marijuana consumption led to reduced scores for depression and anger, among other emotional expressions, and also led to heightened vigor in the same patients.
In 2020, a review by researchers at New Mexico University found that cannabis was useful in treating depression symptoms. Antidepressant drugs have had negative effects on bipolar patients, but cannabis checks for safety, effectiveness and natural remedy for the treatment of bipolar disorder. There has been a positive impact on the neuroendocrine, neurotransmission and neuroimmune systems when the endocannabinoid system is boosted with the use of cannabinoid-based products. These are the systems adversely affected by bipolar disorder, resulting in depression and other mood disorders.
A 2006 Montreal study also discovered that increasing endocannabinoids produced by the brain increases effectiveness in one’s mood. According to the lead researcher, this was the first time a drug that increased cannabinoids in the brain also improved one’s mood. Another 2020 report from BMC Psychiatry showed that the whole cannabis plant and other plant-based cannabinoids do improve mood and sleep but also reduce anxiety and psychotic disorders.
The research body on cannabis for bipolar disorders is in its infancy, but the studies do show promise. With expanded research and clinical trials, bipolar patients will have a plethora of options outside of the conventional drugs that pharmaceutical giants are availing on the market.
As the therapeutic potential of this plant is confirmed for different medical indication, there could be a spike in the number of people looking for cannabis-growing equipment from manufacturers such as Advanced Container Technologies Inc. (OTC: ACTX) in a bid to have access to this life-changing medication cost-effectively.
NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Cannabis has proved to have an effect in improving cognitive functions all the while helping to reduce risky decision-making, new research has found. Currently, more than 40 million people suffer from bipolar disorders globally. Bipolar disorder, or manic depression, has catastrophic effects on one’s daily endeavors including relationships and work processes. In this data, a good number of people suffer mild or extreme aspects of bipolar disorder but are unaware of the diagnosis.
Bipolar disorder is categorized in two main sets: bipolar I, where one exhibits manic episodes lasting a week or so, such an individual may need hospitalization; and bipolar II, where a patient presents with manic depressive episodes and elevated mood swings that could agitate the patient. Those agitating episodes could lead to high energy in the patients. The patient could also exhibit a cyclothymic disorder where they present with cyclical rapid high-low emotions or mood swings. These mood swings alternate from high-energy excitedness to a depressive dip in a small span of time.
Conventional medicine has been of help in alleviating the symptoms. However, many patients under conventional psychotic drugs do not seem to find much relief because, for one, the drugs take a long time before the effects kick in, and these drugs come with a myriad of side effects. Cannabis has come in handy as a natural and safe alternative for bipolar patients.
In a new study, researchers presented some findings in the Neuroscience 2022 conference seeking to understand how cannabis affects the cognitive and goal-directed behaviors among people with bipolar disorder. This study revealed that marijuana may have uniquely beneficial effects for those consuming it chronically. Researchers said that marijuana was effective specifically in improving cognitive function while also reducing risky decision-making. The researchers also deduced that cannabis reduces the dopaminergic activity in the brain to suppress bipolar symptoms.
There have been other older studies that produced similar findings. In a 2018 clinical trial, researchers discovered that consumption of cannabis improved the clinical symptoms of bipolar disorder. This was the first-ever clinical trial to be conducted with the aim of understanding how marijuana affects neuropsychological performance.
Researchers from Harvard Medical School, in conjunction with other scientists, studied the impact of cannabis on cognitive function and mood among bipolar patients. They found that marijuana consumption led to reduced scores for depression and anger, among other emotional expressions, and also led to heightened vigor in the same patients.
In 2020, a review by researchers at New Mexico University found that cannabis was useful in treating depression symptoms. Antidepressant drugs have had negative effects on bipolar patients, but cannabis checks for safety, effectiveness and natural remedy for the treatment of bipolar disorder. There has been a positive impact on the neuroendocrine, neurotransmission and neuroimmune systems when the endocannabinoid system is boosted with the use of cannabinoid-based products. These are the systems adversely affected by bipolar disorder, resulting in depression and other mood disorders.
A 2006 Montreal study also discovered that increasing endocannabinoids produced by the brain increases effectiveness in one’s mood. According to the lead researcher, this was the first time a drug that increased cannabinoids in the brain also improved one’s mood. Another 2020 report from BMC Psychiatry showed that the whole cannabis plant and other plant-based cannabinoids do improve mood and sleep but also reduce anxiety and psychotic disorders.
The research body on cannabis for bipolar disorders is in its infancy, but the studies do show promise. With expanded research and clinical trials, bipolar patients will have a plethora of options outside of the conventional drugs that pharmaceutical giants are availing on the market.
As the therapeutic potential of this plant is confirmed for different medical indication, there could be a spike in the number of people looking for cannabis-growing equipment from manufacturers such as Advanced Container Technologies Inc. (OTC: ACTX) in a bid to have access to this life-changing medication cost-effectively.
NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
(0)
(0)